TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of p60 c-Src tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of p60 c-Src tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of p60 c-Src tyrosine kinase mediated phosphorylation of Fak in IC8.1 fibroblastsMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1/ABL2(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of v-Abl tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of p60 c-Src tyrosine kinase activityMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1/ABL2(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of v-Abl tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of p60 c-Src tyrosine kinase mediated phosphorylation of Fak in IC8.1 fibroblastsMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of p60 c-Src tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of p60 c-Src tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of p60 c-Src tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of v-Abl tyrosine kinase activityMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1/ABL2(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of v-Abl tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of p60 c-Src tyrosine kinase activityMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1/ABL2(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of v-Abl tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 42nMAssay Description:Inhibition of p60 c-Src tyrosine kinase mediated phosphorylation of Fak in IC8.1 fibroblastsMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1/ABL2(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibition of p60 c-Src tyrosine kinase mediated phosphorylation of Fak in IC8.1 fibroblastsMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibition of p60 c-Src tyrosine kinase mediated phosphorylation of Fak in IC8.1 fibroblastsMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Inhibition of v-Abl tyrosine kinase activityMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1/ABL2(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 85nMAssay Description:Inhibition of p60 c-Src tyrosine kinase mediated phosphorylation of Fak in IC8.1 fibroblastsMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1/ABL2(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 90nMAssay Description:Inhibition of v-Abl tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 100nMAssay Description:Inhibition of p60 c-Src tyrosine kinase mediated phosphorylation of Fak in IC8.1 fibroblastsMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 100nMAssay Description:Inhibition of p60 c-Src tyrosine kinase enzymeMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1/ABL2(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of v-Abl tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of p60 c-Src tyrosine kinase activityMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1/ABL2(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of p60 c-Src tyrosine kinase mediated phosphorylation of Fak in IC8.1 fibroblastsMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of p60 c-Src tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Inhibition of v-Abl tyrosine kinase activityMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1/ABL2(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Inhibition of v-Abl tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of p60 c-Src tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of p60 c-Src tyrosine kinase mediated phosphorylation of Fak in IC8.1 fibroblastsMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of p60 c-Src tyrosine kinase mediated phosphorylation of Fak in IC8.1 fibroblastsMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1/ABL2(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 230nMAssay Description:Inhibition of p60 c-Src tyrosine kinase activityMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity More data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1/ABL2(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 260nMAssay Description:Inhibition of v-Abl tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:Inhibition of p60 c-Src tyrosine kinase mediated phosphorylation of Fak in IC8.1 fibroblastsMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:Inhibition of p60 c-Src tyrosine kinase mediated phosphorylation of Fak in IC8.1 fibroblastsMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 330nMAssay Description:Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity More data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1/ABL2(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 340nMAssay Description:Inhibition of p60 c-Src tyrosine kinase mediated phosphorylation of Fak in IC8.1 fibroblastsMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1/ABL2(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 390nMAssay Description:Inhibition of p60 c-Src tyrosine kinase activityMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 400nMAssay Description:Inhibition of p60 c-Src tyrosine kinase mediated phosphorylation of Fak in IC8.1 fibroblastsMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1/ABL2(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 420nMAssay Description:Inhibition of v-Abl tyrosine kinase activityMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 420nMAssay Description:Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 440nMAssay Description:Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 450nMAssay Description:Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 460nMAssay Description:Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 480nMAssay Description:Inhibition of p60 c-Src tyrosine kinase activityMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 490nMAssay Description:Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Novartis Pharma Research
Curated by ChEMBL
Novartis Pharma Research
Curated by ChEMBL
Affinity DataIC50: 500nMAssay Description:Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity More data for this Ligand-Target Pair